Skip to Content

Clinical Experience

Genitourinary-0484_600

The goal of the fellowship is to provide the candidate with specialized training in the evaluation and treatment of urologic malignancies, as well as the background to assess and contribute to the field of research in urologic oncology.

Annually at UW hospital, the Department of Urology performs more than 7,500 clinical and surgical patient encounters for genitourinary cancers. These include:

Bladder Cancer Procedures

  • Open and Robotic Cystectomy
  • Ileal Loop and Neobladder Diversions

Prostate Cancer Procedures

  • Open and Robotic Prostatectomy
  • Interstitial Prostate Brachytherapy

Kidney Cancer Procedures

  • Laparoscopic, Robotic and Open Radical Nephrectomy
  • Robotic and Open Partial Nephrectomy
  • Excision of Metastatic Lesions
  • Percutaneous CT Guided Renal Tumor Ablation

Testicular Cancer Procedures

  • Robotic and Open RPLND
  • Postchemotherapy RPLND

Penile Cancer Procedures

  • Partial and Total Penectomy
  • Glans Sparing Penile Cancer Procedures
  • Inguinal Lymph Node Dissection

Fellows will gain a broad experience using modern methods for diagnosing and treating urologic cancers, including weekly interdisciplinary interactions with radiation oncology, medical oncology, radiology and genitourinary pathology. Strong interdisciplinary training is provided with a large genitourinary medical oncology group (leader: George Wilding, MD), radiation oncology (Mark Ritter, MD, PhD) and GU pathology (Wei Huang, MD). The fellow is exposed to a wide array of primary and advanced clinical experiences through these interactions.

  • Individual rotations with medical oncology and radiation oncology are integrated into the curriculum to facilitate a rounded education in treatment of genitourinary cancer treatment.

The Department of Urology has a history of pioneering minimally invasive surgical procedures, and fellows will receive advanced training in minimally invasive and open surgical techniques for urologic oncology.

  • After completion of Urologic Oncology training at the UW, fellows will have gained valuable experience in all of the major surgical procedures involving bladder cancer, prostate cancer, kidney cancer, penile cancer, adrenal cancer and testes cancer.
  • Fellows will be exposed to emerging new surgical technology and cutting edge techniques for cancer treatment through an active clinical trials program at the UW.
  • Fellows will actively participate in a high volume of surgical procedures with the Oncology faculty during their clinical training including (estimated volumes from prior training years)
    • Prostatectomies — 250 per year, robotic and open approaches
    • Nephrectomies — 100 per year, robotic, laparoscopic and open approaches including IVC thrombectomies and lymph node dissections
    • Cystectomy with urinary diversion — 100 per year including experience with neobladder and pouch diversions
    • Complex lymph node dissections (not including pelvic LND) — 75 per year, retroperitoneal lymph node dissections and inguinal lymph node dissections for urologic cancers

Downs_OR
Dr. Tracy Downs uses Cysview®, a new diagnostic technology to help physicians better detect and treat bladder cancer.


webmaster@surgery.wisc.edu Copyright © 2017 The Board of Regents of the University of Wisconsin System